Published in Anal Quant Cytol Histol on December 01, 1992
Natural history of progression after PSA elevation following radical prostatectomy. JAMA (1999) 14.35
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am (2001) 5.39
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37
Prostate specific antigen: a decade of discovery--what we have learned and where we are going. J Urol (1999) 3.19
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology (2000) 2.35
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol (2001) 2.32
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am (1997) 2.07
Prostate-specific antigen: what's new in 1997. Oncology (Williston Park) (1997) 2.06
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology (1995) 2.00
Markov regression models for time series: a quasi-likelihood approach. Biometrics (1988) 1.98
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol (1996) 1.98
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res (1998) 1.92
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol (1994) 1.87
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology (1997) 1.79
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72
Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev (1996) 1.64
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol (1998) 1.60
Cardiovascular reactivity to the cold pressor test as a predictor of hypertension. Hypertension (1989) 1.56
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology (1995) 1.56
Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A (1989) 1.55
Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol (1998) 1.50
Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology. Urology (1999) 1.49
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol (1997) 1.46
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Identification and characterization of circulating prostate carcinoma cells. Cancer (2000) 1.41
Comparison of robotic versus human laparoscopic camera control . J Urol (1995) 1.40
Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci (1998) 1.39
32P following negative second-look laparotomy for epithelial ovarian cancer. Gynecol Oncol (1993) 1.38
Rapid infusion of additive red blood cells: alternative techniques for massive hemorrhage. Ann Emerg Med (1990) 1.38
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38
The effect of hospital volume on cancer control after radical prostatectomy. J Urol (2005) 1.36
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol (1998) 1.34
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33
Partial nephrectomy: technique, complications and pathological findings. J Urol (1995) 1.30
Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer (1997) 1.29
Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology (2001) 1.24
Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res (1989) 1.24
Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res (1996) 1.23
Heredity and prostate cancer: a study of World War II veteran twins. Prostate (1997) 1.22
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol (1989) 1.20
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res (1998) 1.20
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate (1999) 1.20
Influence of radical prostatectomy on serum hormone levels. J Urol (1998) 1.19
Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostate. Prostate (1999) 1.19
The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol (2000) 1.17
Telementoring of laparoscopic procedures: initial clinical experience. Surg Endosc (1996) 1.17
Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol (1999) 1.16
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology (2001) 1.16
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis (1997) 1.16
Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl (1999) 1.14
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology (1999) 1.11
Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum Pathol (1996) 1.11
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology (1999) 1.10
An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology (1998) 1.10
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy. Ann Oncol (2013) 1.10
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology (2000) 1.10
Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol (1998) 1.09
Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology (2000) 1.07
HE2beta and HE2gamma, new members of an epididymis-specific family of androgen-regulated proteins in the human. Endocrinology (2000) 1.07
Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings. Urology (1999) 1.07
Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol (1987) 1.05
Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications. J Urol (1994) 1.05
Sclerosing lipogranulomatosis: a case report of scrotal injection of automobile transmission fluid and literature review of subcutaneous injection of oils. Plast Reconstr Surg (1993) 1.05
New laparoscopic suturing device: initial clinical experience. Urology (1995) 1.05
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis (1999) 1.03
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol (2000) 1.02
Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology (1997) 1.02
Using an office system intervention to increase breast cancer screening. J Gen Intern Med (1998) 1.02
Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol (1999) 1.01
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology (1996) 1.01
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. J Urol (1996) 1.01
Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience. Urology (1994) 1.00
The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control (2000) 1.00
Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft. J Androl (2001) 1.00
Long-term effects of finasteride on prostate tissue composition. Urology (1999) 1.00
DNA loop domains in mammalian spermatozoa. Chromosoma (1989) 0.99
Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer (1992) 0.98
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer? Urology (2001) 0.98
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J Urol (1989) 0.98
Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev (1996) 0.97
Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations. J Cell Biochem Suppl (2000) 0.97
Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology (2001) 0.97
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer. Urology (1999) 0.97
Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology (1999) 0.96
Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology (1997) 0.96
Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia. Hum Pathol (1998) 0.96
Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J Urol (1993) 0.95
In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn Reson Med (1993) 0.94
Ability of sextant biopsies to predict radical prostatectomy stage. Urology (1998) 0.94
The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate (1993) 0.94